Latest Articles
Parents say cancer care delays cost daughter time - AOL.com
Parents say cancer care delays cost daughter time AOL.com
Published: April 4, 2026, 7:32 a.m.
The future of endometrial cancer screening - AOL.com
The future of endometrial cancer screening AOL.com
Published: April 4, 2026, 6:56 a.m.
A new test could transform endometrial cancer diagnosis - AOL.com
A new test could transform endometrial cancer diagnosis AOL.com
Published: April 3, 2026, 8:48 p.m.
A new test could transform endometrial cancer diagnosis - ABC News
A new test could transform endometrial cancer diagnosis ABC News
Published: April 3, 2026, 1:40 p.m.
A new test could transform endometrial cancer diagnosis - Good Morning America
A new test could transform endometrial cancer diagnosis Good Morning America
Published: April 3, 2026, 1:36 p.m.
The future of endometrial cancer screening - Good Morning America
The future of endometrial cancer screening Good Morning America
Published: April 3, 2026, 1:10 p.m.
Video The future of endometrial cancer screening - ABC News
Video The future of endometrial cancer screening ABC News
Published: April 3, 2026, 12:52 p.m.
ATM IHC Identifies POLE-Mutant Endometrial Cancer - Conexiant
ATM IHC Identifies POLE-Mutant Endometrial Cancer Conexiant
Published: April 2, 2026, 9:11 p.m.
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? - The ASCO Post
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? The ASCO Post
Published: April 2, 2026, 4:19 p.m.
Endometrioid Versus Seromucinous Borderline Ovarian Tumors: Divergent Molecular Signatures and a Shared Role as Precursors to Endometrioid Carcinoma.
Endometrioid borderline tumors (EBTs) and seromucinous borderline tumors (SMBTs) are rare ovarian neoplasms with distinct histologic features. However, the molecular profiles of EBTs and SMBTs remain incompletely characterized. We performed …
Published: April 2, 2026, midnight
Link copied to clipboard!